Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Year range
1.
J. bras. med ; 94(3): 53-62, Mar. 2008. tab
Article in Portuguese | LILACS | ID: lil-619653

ABSTRACT

A doença arterial coronariana é altamente prevalente na população e uma das principais causas de óbito em nossa sociedade. O reconhecimento precoce e o adequado tratamento desta síndrome clínica podem evitar complicações e minimizar os riscos. Em 2007, o American College of Cardiology e a American Heart Association revisaram o Guideline de Manejo de Pacientes com AI e IAM SSST, produzido em 2002, com o intuito de facilitar o reconhecimento, diagnóstico e tratamento desta importante síndrome clínica. O presente artigo tem como objetivo salientar as características principais dessas síndromes clínicas, assim como transmitir os principais aspectos abordados pelo Guideline publicado em 2007 pelo American College of Cardiology e a American Heart Association.


Coronary artery disease is highly prevalent in general population and one of the main causes of death in our society. Early recognition and proper therapy of this syndrome can avoid complications and curtail risks. In 2007 the American College of Cardiology and the American Heart Association reviewed the Guidelines for Patient Management with UA and non-STMI, published in 2002, in order to ease the recognition, diagnosis and therapy of this important clinical condition. This paper aims to give a clear picture of the main characteristics of these syndromes, as well as the highlights of the Guideline published in 2007 by the American College of Cardiology and the American Heart Association.


Subject(s)
Humans , Male , Female , Angina, Unstable/physiopathology , Angina, Unstable/therapy , Adrenergic beta-Antagonists/therapeutic use , Anticoagulants/therapeutic use , Aspirin/therapeutic use , Calcium Channel Blockers/therapeutic use , Myocardial Infarction/physiopathology , Myocardial Infarction/therapy , Platelet Aggregation Inhibitors/therapeutic use , Nitrates/therapeutic use , Coronary Artery Disease/therapy , Risk Assessment/methods
SELECTION OF CITATIONS
SEARCH DETAIL